Beth Israel Deaconess Medical Center (BIDMC) https://www.bidmc.org and Deerfield Management https://deerfield.com, a healthcare investment firm, recently announced a research collaboration to accelerate discovery of novel therapeutics.
Deerfield Management will provide up to $130 million along with additional scientific and operational support to advance BIDMC research that has the potential to transform patient care over the next decade.
A key partner in the collaboration is BIDMC’s Translational Research Hubs which are multidisciplinary research and clinical teams focusing on therapeutic areas and technology platforms that align with the needs of BIDMC’s patient population.
The hubs aim to maximize collaboration among physicians, scientists, students and trainees to give members the opportunity to learn from one another and in turn, launch novel scientific and medical discoveries.
BIDMC researchers will be able to submit proposals for funding to Deerfield’s scientific review team. Accepted proposals will work with Brookline Avenue Innovations, LLC, a newly formed private company wholly owned by affiliates of Deerfield Management, to specifically manage and support BIDMC projects. Selected projects will also be eligible for additional capital investments to create spin-off companies.